Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence

Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence

Vaccines remain the cornerstone of medical prevention and are highly effective in reducing the risk of severe disease and death due to coronavirus disease 2019 (COVID-19). In the context of expanding the therapeutic armamentarium against COVID-19, molnupiravir (Lagevrio) and ritonavir-boosted nirmat...

Full description

Bibliographic Details
Main Authors: Ioannis Karniadakis, Nikolaos Mazonakis, Constantinos Tsioutis, Michail Papadakis, Ioulia Markaki, Nikolaos Spernovasilis
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Infectious Disease Reports
Subjects:
COVID-19
pandemic
SARS-CoV-2
oral antivirals
Paxlovid
ritonavir
Online Access:https://www.mdpi.com/2036-7449/15/6/61

Internet

https://www.mdpi.com/2036-7449/15/6/61

Similar Items